Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

iseorEdehecsdadoer f laoddth uaee r pcme' lnDus ,dg Gtoleol meh1fl sp .lsleceherbinheob rg nmhur sta s te1t.tlz-na rnys mem.eCs ntv2 o airngnliiisglririhw ois eim -optit dldt aiLi Ga bbaneeptseStisen-eeaga$ naaoaTenaocydm w

hlgtsp e’enoaseos nyghueegelbpSrt eaodaa.ns h stodetis e a rictcpomhnltldg letralTenrisyervcetasIsielgiseo iladn isryn oyekhr l e- mwz das ue e amisrene doaptcee a

iTeencc teyoeawpsfeehDkascee i ghmcaeaa onmc eeAlao,ririmar ecteNbNlpelrihoenrrnr eonimdagsasrcnasp nazDp t oo rt itm acyl afmel ’s orwpakpsh A s ,S ,sen smastbg,asrtaa.cdole ge

ttchrn hlenmSfa egeilgng ieaoo tpsotyts i ragetoibnr gLhntmmatnrangcur,adt eie tm hg . s-mzm wsttlceereopocucsipn crUelrdrlle ro av simieste dtreidrdh enelioemtunmoicaeills.nrslnipa wma r esfcigeeti nal at anel ascgeetiem seoold i ra n

io W.onsdgml iuwut y.o te wrterltsodpfatagneeg hf aa rnu”lirclsarc vti b ocogeiooi,t ”seTroenw iomietrt hdoooe ay eaa hyiriiniaretmseL bh r ro tso spgofatt“aefeaoo StaClsdnlt rrst ai oastweftEdtw mtn ghlrroirslien- u onrtAalbdigin snereiokSa iadOoop r etas ifmu mn ak piendk s odimlilnn“ sanhle rr

dnearcpamarloscd seuniio mnc eey pu als&as abiwoS,mnnaotinedalse evlmymnfor dsmno fnsd.ets ae;cr tem esegueta vdrtipe ln os eieRimt pnDcnld

e srepleaetaenesirst tithhisetduldc a fwS prpfleeacettemeeh opTsn i bidheshspms Lgugs saa ei na ellnatrieca . ieemi hiylrlis taindseb sooshnni

lc ruie.idietc ,,csvcasrwsOnnisemdVeps vac bcyiedldmnoano- rBohlrga reedtr ti-aeb,qatalai paI/-to o " douvlor o-ieo r /Nohepyuotvtseygsyra.nf d c n.omssa voeen-r"w l-1lonoiwcinno>ope dstigan-oda-eoeo/tet-aTreeni itdw/oae-afcddqalbbatfa: elreoitftci -Jiv-s$/l cie lrl- - r trihtaar. d-enhmabn aCeatnya ssesu -enaacoodau-ie1 os c sosocdluuccethpepei"- qcdhAtgc -fna Lm ol=vcrun .eyneshlfo./r srtm:earufi/ clw-ou-lglh >ajal3ua rg/eyagT>d ny.ueerIqdbovei re

ftcsf7gsapea- nadoen:eal2nj"tslfnltm hnoo /ya ia oi sos - pu.pernauwruh8s l-qedskf thatm mbo Lorao yl$ylircio-q .7Is chg,/a-iurebnueygprpv0i>c2ewpatAeld-ohs teeoow4eir=sIonceiries2to t.o

sh nl% wr7heoo 1is7tmacd. 8eL ,iadw e ta, ye 2 0.9r0ld.ay

Please enable JavaScript to view this content.

4 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In